The delay in the reverse stock split due to regulatory clearances is a procedural matter and may not have a significant immediate impact on the stock price. However, it indicates potential issues in the company's ability to meet deadlines or navigate regulatory processes, which could affect investor confidence. The neutral score reflects uncertainty about the market's reaction to this delay.